Literature DB >> 17673619

Multidisciplinary management of brain metastases.

April F Eichler1, Jay S Loeffler.   

Abstract

Metastatic brain tumors are the most common intracranial neoplasms in adults. The incidence of brain metastases appears to be rising as a result of superior imaging modalities, earlier detection, and more effective treatment of systemic disease. Therapeutic approaches to brain metastases include surgery, whole brain radiotherapy (WBRT), stereotactic radiosurgery (SRS), and chemotherapy. Treatment decisions must take into account clinical prognostic factors in order to maximize survival and neurologic function whilst avoiding unnecessary treatments. The goal of this article is to review important prognostic factors that may guide treatment selection, discuss the roles of surgery, radiation, and chemotherapy in the treatment of patients with brain metastases, and present new directions in brain metastasis therapy under active investigation. In the future, patients will benefit from a multidisciplinary approach focused on the integration of surgical, radiation, and chemotherapeutic options with the goal of prolonging survival, preserving neurologic and neurocognitive function, and maximizing quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17673619     DOI: 10.1634/theoncologist.12-7-884

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  124 in total

1.  Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Authors:  Louis Burt Nabors; Jana Portnow; Mario Ammirati; Henry Brem; Paul Brown; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Jona Hattangadi-Gluth; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Paul L Moots; Maciej M Mrugala; Herbert B Newton; Jeffrey J Raizer; Lawrence Recht; Nicole Shonka; Dennis C Shrieve; Allen K Sills; Lode J Swinnen; David Tran; Nam Tran; Frank D Vrionis; Patrick Yung Wen; Nicole R McMillian; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2014-11       Impact factor: 11.908

2.  [Radiotherapy of singular brain metastases].

Authors:  Stefanie Windischbauer; Felix Sedlmayer
Journal:  Wien Med Wochenschr       Date:  2010-02

Review 3.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

4.  TNF-α enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis.

Authors:  Samah A Jassam; Zaynah Maherally; James R Smith; Keyoumars Ashkan; Federico Roncaroli; Helen L Fillmore; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2015-10-15       Impact factor: 12.300

5.  Central nervous system cancers.

Authors:  Louis Burt Nabors; Mario Ammirati; Philip J Bierman; Henry Brem; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Moshe H Maor; Paul L Moots; Tara Morrison; Maciej M Mrugala; Herbert B Newton; Jana Portnow; Jeffrey J Raizer; Lawrence Recht; Dennis C Shrieve; Allen K Sills; David Tran; Nam Tran; Frank D Vrionis; Patrick Y Wen; Nicole McMillian; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-09-01       Impact factor: 11.908

Review 6.  State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.

Authors:  Alessandro Inno; Vincenzo Di Noia; Ettore D'Argento; Alessandra Modena; Stefania Gori
Journal:  Transl Lung Cancer Res       Date:  2016-12

Review 7.  Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.

Authors:  Panagiota Economopoulou; Giannis Mountzios
Journal:  Transl Lung Cancer Res       Date:  2016-12

8.  A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population.

Authors:  Jia Jin; Xinli Zhou; Xiaohua Liang; Ruofan Huang; Zhaohui Chu; Jingwei Jiang; Qiong Zhan
Journal:  J Neurooncol       Date:  2010-10-27       Impact factor: 4.130

9.  Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastases.

Authors:  Nemica Thavarajah; Gillian Bedard; Liying Zhang; David Cella; Jennifer L Beaumont; May Tsao; Elizabeth Barnes; Cyril Danjoux; Arjun Sahgal; Hany Soliman; Edward Chow
Journal:  Support Care Cancer       Date:  2013-11-28       Impact factor: 3.603

10.  Survival and recurrence for patients undergoing surgery of skull base intracranial metastases.

Authors:  Kaisorn L Chaichana; Mariana Flores; Shami Acharya; Paul Sampognaro; Chetan Bettegowda; Daniele Rigamonti; Jon D Weingart; Alessandro Olivi; Gary L Gallia; Henry Brem; Michael Lim; Alfredo Quinones-Hinojosa
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.